Dr. Angela Maria Curiale, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 6060 Sunrise Vista Dr, Ste 3110, Citrus Heights, CA 95610 Phone: 916-560-9507 Fax: 916-560-9507 |
Ms. Marietta Louise Rubien, LCSW Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8084 Old Auburn Rd, Suite C, Citrus Heights, CA 95610 Phone: 916-723-9773 |
Alicia Marie Beaudoin, BCABA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6400 Tupelo Dr, Citrus Heights, CA 95621 Phone: 916-605-9545 |
Dr. Karen Jennifer Abuzahra, PSYD Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 5736 Mariposa Ave, Citrus Heights, CA 95610 Phone: 607-216-7180 |
Denise W Henderson, MD/ABPN Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 6060 Sunrise Vista Dr, Suite 2200, Citrus Heights, CA 95610 Phone: 916-721-8100 Fax: 916-721-8117 |
Jean M. Neill, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 8340 Auburn Blvd Ste 150, Citrus Heights, CA 95610 Phone: 916-771-2425 Fax: 916-771-2425 |
Robert Ryan Lucas Gunton, PHD Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 8421 Auburn Blvd Ste 110, Citrus Heights, CA 95610 Phone: 916-531-8359 |
News Archive
VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.
A University of Virginia Health System team is working with local rescue squads to diagnose stroke patients before they reach the hospital, enabling more patients to receive lifesaving treatment and have a full recovery.
Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation.
Patients with heart failure with preserved ejection fraction who took the antifibrotic drug pirfenidone saw a significant reduction in a marker of heart muscle scarring compared with patients who received a placebo, based on findings from an early-phase trial presented at the American College of Cardiology's 70th Annual Scientific Session.
› Verified 2 days ago